Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method and application of large proliferation of newborn mouse skin terminally isolated cells

A cell and skin technology, applied in the field of massive expansion of skin terminal cells in newborn rats, can solve the problems of small number, unfavorable experiments, low purity, etc., and achieve the effect of high vitality, high cell purity, and large number of cells

Pending Publication Date: 2018-11-23
XINXIANG MEDICAL UNIV
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, in the esophagus, type II collagenase and deoxyribonuclease are configured as digestive fluid, the centrifugation rate of cells is 2000rpm, the cell culture differential attachment time is 60-90 min, and the cell culture medium is high-sugar DMEM medium; for Primary isolation and culture of skin TCs, tissue digestion solution is 0.05% collagenase P and 0.1% trypsin; however, the number of TCs isolated and cultured by these methods is small and the purity is low, which is not conducive to carrying out subsequent related experiments

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and application of large proliferation of newborn mouse skin terminally isolated cells
  • Method and application of large proliferation of newborn mouse skin terminally isolated cells
  • Method and application of large proliferation of newborn mouse skin terminally isolated cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0032] The technical solutions of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0033] 1. Experimental materials

[0034] Rat skin samples (1-3d neonatal SD rats), 0.05% collagenase II (Roche Company), 0.05% trypsin (Sigma Company), DMEM (Hyclone Company), 10% fetal bovine serum (Hyclone Company).

[0035] 2. Experimental steps

[0036] Take rat spleen samples under aseptic conditions, rinse with pre-cooled PBS containing 1% penicillin-streptomycin, and cut rat skin tissue into about 1 mm with ophthalmic scissors 3 For small pieces, add an equal volume of digestive enzyme...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of animal cell culture, and relates to a method and application of large proliferation of newborn mouse skin terminally isolated cells. The method comprises the following steps that a newborn mouse skin sample is pretreated; an enzyme digestive liquid is prepared; the sample is treated by the enzyme digestive liquid, and terminally isolated cell suspension liquid is obtained; primary cells of the newborn mouse skin terminally isolated cells are prepared; passage and expansion culture is conducted on the primary cells; passage cells are prepared; andthe skin terminally isolated cells are screened and purified by a c-kit+ / CD34+ flow cytometry, the cell sap is resuspended and subjected to expansion culture, and the skin terminally isolated cells with the high purity are prepared. The method adopts collagenase II and trypsin with the concentration being both 0.05% to separate and culture the skin terminally isolated cells by combining with a digestion method, the number of the obtained primary terminally isolated cells is large, the purity is high, the activity is good, the cells can be rapidly and largely proliferated after being screenedby the flow cytometry, and the proliferated cells are stable in morphology and high in activity, and can be widely applied to morphological detection and function research of the follow-up related terminally isolated cells.

Description

technical field [0001] The invention relates to the technical field of animal cell culture, in particular to a method for amplifying a large number of neonatal rat skin terminal septal cells and its application. Background technique [0002] Telocytes (TCs), a newly discovered and named interstitial cell, are widely distributed in skin, heart, kidney, liver, gastrointestinal tract, bladder, parotid gland, placenta, lung, bronchi and brain, etc. in an organization. Septal terminal cells have typical morphological features: small cell body, one or more elongated processes (telopodes, TPs) of different lengths protruding from the cell body, with constriction (podomer) and enlargement (podom) on the protrusions Arranged alternately, showing a bead-like structure, forming a complex three-dimensional network with surrounding mesenchymal cells. [0003] For the identification of terminal septal cells, observation of tissue-level morphological characteristics by transmission elect...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/071
CPCC12N5/0625C12N2509/00
Inventor 常玉巧李辞霞贾阳阳杨记超韩贝郭志坤
Owner XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products